4
Changes in Ownership
ADMA BIOLOGICS, INC. Filed Acc 0001140361-25-009928
President and CEO sold 21,000 shares at $18.92 ($397,320)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grossman Adam S President and CEO | 2025-03-19 | Option exercise 10b5-1 | +15,000 | $5.40 | $81,000 | 2,082,850 | D: show line 1 in the form |
| Grossman Adam S President and CEO | 2025-03-19 | Sale 10b5-1 | −15,000 | $18.92 | $283,800 | 2,067,850 | D: show line 2 in the form |
| Grossman Adam S President and CEO | 2025-03-19 | Sale 10b5-1 | −6,000 | $18.92 | $113,520 | 2,061,850 | D: show line 3 in the form |
| Open-market sales · 21,000 sh · avg $18.92 · $397,320 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grossman Adam S President and CEO | 2025-03-19 | Option exercise · Common Stock 10b5-1 | −15,000 | 855,950 | D: show line 4 in the form |
Loading xslF345X05/form4.xml…